Seeking Alpha12dAutomated tone · neutral
AbbVie, Amgen, Pfizer, GSK among participants in new 340B rebate pilotInvesting.com13dAutomated tone · neutral
David J. Taylor Purchases Amgen and Home Depot Stocks, Sells Marathon PetroleumInvesting.com23dAutomated tone · neutral
Amgen, Vicor among market cap stock movers on TuesdaySeeking Alpha23dAutomated tone · bullish
Amgen gains on late-stage trial win for Sjögren's disease therapyYahoo Finance28dAutomated tone · neutral
A Failed Cholesterol Drug Raises the Stakes for Amgen (AMGN) and Eli Lilly (LLY) TooYahoo Finance32dAutomated tone · neutral
Amgen (AMGN) Fell 5% on a Drug That Isn’t Even Its Own. Here’s the Lp(a) Bet Now in Question.Seeking Alpha32dAutomated tone · neutral
Notable healthcare headlines for the week: UnitedHealth, Amgen, and CooperCompanies in focusInvesting.com37dAutomated tone · neutral
Amgen and AstraZeneca report positive lung cancer trial resultsSeeking Alpha37dAutomated tone · neutral
Amgen, Astra drug combo extends survival in late-stage trial for lung cancerSeeking Alpha37dAutomated tone · bearish
Amgen drops on Novartis trial setback for heart therapy; BMO downgradesCNBC38dAutomated tone · neutral
Cholesterol drug setback casts doubt over multibillion-dollar raceInvesting.com44dAutomated tone · neutral
UK regulator suspends Amgen rare-disease drug Tavneos for new patientsYahoo Finance45dAutomated tone · neutral
How Is Amgen’s Stock Performance Compared to Other General Drug ManufacturersSeeking Alpha45dAutomated tone · bearish
Amgen's Repatha cuts death risk by 20% in heart studySeeking Alpha48dAutomated tone · neutral
Amgen, Astra post late-stage trial win for asthma drug Tezspire in swallowing disorderInvesting.com58dAutomated tone · bullish
Amgen stock hits all-time high at 422.49 USDInvesting.com63dAutomated tone · neutral
Amgen SVP Rachna Khosla sells $1.35m of stockInvesting.com69dAutomated tone · neutral
Amgen SVP & CCO Nancy Grygiel disposes of $1.19m in stockInvesting.com69dAutomated tone · neutral
Amgen SVP sells $1.56m in stock after option exerciseYahoo Finance71dAutomated tone · neutral
Amgen Hikes Sales Outlook By $1 Billion After Second-Quarter SmashSeeking Alpha72dAutomated tone · neutral
Amgen in charts: Q2 sales in Enbrel and Otezla bounce back Q/Q amid ongoing Y/Y headwindsSeeking Alpha72dAutomated tone · neutral
Amgen outlines raised 2026 guidance of $38.2B-$39.4B revenue and $22.30-$23.50 non-GAAP EPS as CFO transition nearsInvesting.com72dAutomated tone · bullish
Amgen Q2 2026 slides: six growth drivers fuel 10% revenue jumpInvesting.com72dAutomated tone · bullish
Amgen Q2 2026 slides: six growth drivers fuel 10% revenue beatSeeking Alpha72dAutomated tone · bullish
Amgen raises 2026 EPS, revenue guidance as Q2 beats on both linesInvesting.com72dAutomated tone · bullish
Earnings call transcript: Amgen beats Q2 2026 estimates and raises guidanceSeeking Alpha72dAutomated tone · bullish
Earnings Snapshot: Amgen Q2 six growth drivers soar 26% YoY as EPS, revenue beat estimatesYahoo Finance73dAutomated tone · neutral
Amgen contends with data breach, exposing patient informationInvesting.com76dAutomated tone · neutral
Amgen discloses data breach involving patient health informationSeeking Alpha76dAutomated tone · neutral
Amgen hit by cybersecurity incident, sensitive data stolenYahoo Finance76dAutomated tone · neutral
Amgen discloses data breach involving patient health informationSeeking Alpha78dAutomated tone · neutral
Amgen gains positive CHMP opinion for Repatha to reduce cardiovascular risk